Global analysis of cancer cell responses to USP9X inhibition
Philipp Schenk, Shane M. Devine, Simon A. Cobbold, Niall D. Geoghegan, Elizabeth L. Kyran, Ching‐Seng Ang, Jack A Alexandrovics, Dale J. Calleja, Dylan H. Multari, Vineet Vaibhav, Bernadine G.C. Lu, Theresa Klemm, Laura F. Dagley, Kym N. Lowes, Nicholas A. Williamson, , David Komander
This study identifies WEHI-092, a USP9X inhibitor, and shows it arrests cancer cells in metaphase, suggesting USP9X inhibitors could be selective mitotic poisons.
The EMBO Journal · Apr 7, 2026Peer-reviewedCell Biology